This new collaboration between Almirall and the group of Prof. Alessio Ciulli at Dundee University aims to discover and develop a class of small-molecule degrader drugs as a novel therapeutic paradigm to treat inflammatory skin diseases with unmet medical needs.
Related links
- Almirall Press Release: Almirall and the University of Dundee announce a multi-target research collaboration to develop novel Targeted Protein Degraders medicines
- Almirall Share news: Research collaboration with University of Dundee
- UoD Press Release: Collaboration to target severe skin diseases
- SLS News: Collaboration to target severe skin diseases
- PR NEwswire: Almirall and the University of Dundee announce a multi-target research collaboration to develop novel Targeted Protein Degraders medicines
- The National: Partnership to tackle severe skin diseases
- Deadline News: Scottish University teams up with global biopharmaceutical company to develop new skin treatment – Health News Scotland
